India ofloxacin market is expected to grow at a steady rate during the forecast period. The India ofloxacin market is driven by high prevalence of bacterial infections in the country. Additionally, increasing resistance by bacteria and mounting requirement for advanced drugs in order to treat bacterial infection caused by pathogens sensitive to ofloxacin is expected to boost the product demand through FY2026. High suitability of the drug for the treatment of skin and soft tissue infections is further predicted to increase the market growth in the years to come.

The India ofloxacin market is segmented based on source, form, route of administration, distribution channel, application, end user, company, and region. Based on form, the market is segmented into tablet, capsule, cream, syrup, injection, eye and ear drops. Among them, the tablet segment was the dominant segment in the market until FY2020 and is further projected to maintain its leading position over the forecast period as well which is attributable to their ease of availability and usage as compared to other alternatives. Besides, properties such as high stability of tablets and longer shelf life are further boosting the segmental growth in the years to come.

The major players operating in the India ofloxacin market are Alkem Laboratories Ltd., Avalanche Pharmaceutical Pvt. Ltd., Bestochem Formulations (India) Ltd., Bennet Pharmaceuticals Ltd., Emcure Pharmaceuticals Ltd., Wockhardt Limited, Intra Labs India Pvt. Ltd., Melody Healthcare Pvt. Ltd., Lupin Laboratories Ltd., Zydus Cadila Healthcare Ltd, and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other inorganic growth strategies include mergers & acquisitions, joint ventures, research collaborations and new product developments for prospering in amidst fierce competition.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India ofloxacin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India ofloxacin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India ofloxacin market based on source, form, route of administration, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India ofloxacin market.
  • To identify drivers and challenges for India ofloxacin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India ofloxacin market.
  • To identify and analyze the profile of leading players operating in India ofloxacin market.
  • To identify key sustainable strategies adopted by market players in India ofloxacin market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India ofloxacin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Ofloxacin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to ofloxacin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India ofloxacin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Ofloxacin Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Ofloxacin Market, By Form:
    • Tablet
    • Capsule
    • Syrup
    • Cream
    • Injection
    • Eye and Ear Drops
  • India Ofloxacin Market, By Route of Administration:
    • Oral
    • Intravenous
    • Topical
    • Ophthalmic
    • Otic
  • India Ofloxacin Market, By Distribution Channel:
    • Online
    • Offline
  • India Ofloxacin Market, By Application:
    • Chronic Bronchitis
    • Conjunctivitis
    • Acute Otitis Media
    • Skin Infections
    • Urinary Tract Infections
    • Cervical Gonorrhoea
  • India Ofloxacin Market, By End User:
    • Adult
    • Paediatric
  • India Ofloxacin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India ofloxacin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India ofloxacin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Ofloxacin Market

4.    Executive Summary

5.    Manufacturing Ofloxacin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Ofloxacin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Ofloxacin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Tablet, Capsule, Cream, Syrup, Injection, Eye and Ear Drops)

7.2.3.     By Route of Administration (Oral, Intravenous, Topical, Ophthalmic and Otic)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (chronic bronchitis, conjunctivitis, acute otitis media, skin infections, urinary tract infections and cervical gonorrhoea)

7.2.6.     By End User (Adult v/s Paediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Alkem Laboratories Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Avalanche Pharmaceutical Pvt. Ltd.

14.1.3.  Bestochem Formulations (India) Ltd.

14.1.4.  Bennet Pharmaceuticals Ltd.

14.1.5.  Emcure Pharmaceuticals Ltd.

14.1.6.  Wockhardt Limited

14.1.7.  Intra Labs India Pvt. Ltd.

14.1.8.  Melody Healthcare Pvt. Ltd.

14.1.9.  Lupin Laboratories Ltd.

14.1.10. Zydus Cadila Healthcare Ltd.

15.  Strategic Recommendations

About Us & Disclaimer